AZTEC: A phase II study of the use of azacitidine for the treatment of patients with chronic graft-versus-host-disease who have failed therapy with corticosteroids

Change of Staff

If there is a change of staff working on the trial please print off and complete the relevant registration form below. Please also ensure that the Signature and Delegation Log is updated. 

Trial Documents

Links to the current protocol, Patient Information Sheet(s), Informed Consent Form(s) are provided below. If there has been a recent amendment to the trial please ensure you have R&D approval before using these documents.

Other documents (e.g. Amendments, Case Report Form, Serious Adverse Event Form, Guidelines, GP Letter, Release of Medical Information Form etc) can be found by clicking on the other menu items below. If you cannot find what you are looking for please contact the AZTEC Trial Office.


Version Control Lists

The version numbers and dates of all documents used for the trial are captured on a Version Control List. Links to the Version Control Lists used in this trial are below in reverse date order.



 The folders below contain the relevant amended documentation and approval letters. Please ensure that you have R&D approval (if applicable) before using the latest versions of these documents.

  • Amendment 01 - Addition of new site/change of PI only
  • Amendment 02 - Change of site/PI details only
  • Amendment 03 [opens new page]
  • Amendment 04 [opens new page]
  • Amendment 05 [opens new page]


Case Report Forms




Other Trial Documents


No publications to date

Contact Details

Chief Investigator

Dr Ram Malladi
Senior Lecturer/Consultant Haematologist
Centre for Clinical Haematology
Queen Elizabeth Hospital
B15 2TH

Tel: +444 (0)121 371 4365
Fax: +44 (0)121 371 4398

AZTEC Trial Office
Trial Coordinator: Tina McLeod                          
Trial Monitor: Karen James                            
Trial Management Team Leader: Shamyla Siddique 
Trial Statistician: Ikhlaaq Ahmed                            

Centre for Clinical Haematology
Research Office
Queen Elizabeth Hospital
B15 2TH

Telephone: +44 (0)121 371 4365
Fax:             +44 (0)121 371 7874

Serious Adverse Event Reporting
Fax: +44 (0)121 371 7874


University of Birmingham

Correspondence to:
Cancer Research UK Clinical Trials Unit (CRCTU)
University of Birmingham
B15 2TT